Keyrus S.A., a consultancy company, engages in the development of data and digital solutions for performance management worldwide. It provides data advisory and consulting services, such as data and AI strategies, roadmap and scoping study, architecture and technology consulting, decision intelligence, and data governance; and data and analytic solutions, including data platforms, visualization and storytelling, quality and governance, and mesh and fabric, as well as cloud data management. The company also offers artificial intelligence (AI) literacy and understanding, strategy and prioritization, testing and development, production and scale-up, modeling and evaluation, and governance services; enterprise performance management services, such as performance analytics, consolidation and regulatory reporting, and profitability and cost management as well as planning, budgeting, and forecasting; and digital and multi-experience services, including digital strategy consulting, customer data platform, marketing automation, and omnichannel commerce. It provides its offerings under the Keyrus Life Science, Absys Cyborg, Younicorns, Vision.bi, and CMG Consulting Group brands. The company was founded in 1996 and is headquartered in Levallois-Perret, France.
This week, we’re going to look at the U.S. regulatory changes, how adoption has been trending, and one of the risks with the ETFs. If you want some exposure to Bitcoin, at the end, we’ll show you some different ways you can position your portfolio accordingly.
The market has climbed 2.2% in the last 7 days, lead by the Consumer Discretionary sector with a gain of 3.2%. The market is up 3.9% over the last 12 months. As for the next few years, earnings are expected to grow by 12% per annum. Market details ›